TNF Receptor-Associated Periodic Syndrome
Symptoms, Doctors, Treatments, Advances & More

TNF Receptor-Associated Periodic Syndrome Overview

Save information for later
Sign Up

Learn About TNF Receptor-Associated Periodic Syndrome

What is the definition of TNF Receptor-Associated Periodic Syndrome?
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) is an inherited condition characterized by recurrent episodes of fever. Episodes can begin at any age but most often begin in early childhood. Fevers typically last about 3 weeks but can last from a few days to a few months. Episodes usually occur spontaneously, but are sometimes brought on by a variety of triggers (such as injury, infection, or stress). Symptoms during fever episodes may include abdominal, muscle or joint pains; skin rashes (usually on the limbs); puffiness around the eyes; and inflammation in various areas of the body. Some people develop amyloidosis. TRAPS is caused by genetic changes in the TNFRSF1A gene and is inherited in an autosomal dominant manner.
What are the alternative names for TNF Receptor-Associated Periodic Syndrome?
  • Tumor necrosis factor receptor-associated periodic syndrome
  • FHF
  • FPF
  • Familial Hibernian fever
  • Hibernian fever, familial
  • Periodic fever, familial, autosomal dominant
  • TNF receptor-associated periodic fever syndrome
  • TNF receptor-associated periodic syndrome
  • TRAPS
Who are the top TNF Receptor-Associated Periodic Syndrome Local Doctors?
Elite in TNF Receptor-Associated Periodic Syndrome
Luca Cantarini
Elite in TNF Receptor-Associated Periodic Syndrome
Luca Cantarini
Siena, IT 

Luca Cantarini practices practicing medicine in Siena, Italy. Mr. Cantarini is rated as an Elite expert by MediFind in the treatment of TNF Receptor-Associated Periodic Syndrome. He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Behcet Disease, Pericarditis, Adult Still's Disease, Lung Transplant, and Splenectomy.

Elite in TNF Receptor-Associated Periodic Syndrome
Donato Rigante
Elite in TNF Receptor-Associated Periodic Syndrome
Donato Rigante
Rome, IT 

Donato Rigante practices practicing medicine in Rome, Italy. Mr. Rigante is rated as an Elite expert by MediFind in the treatment of TNF Receptor-Associated Periodic Syndrome. He is also highly rated in 56 other conditions, according to our data. His clinical expertise encompasses PFAPA, Aphthous Stomatitis, Canker Sore, and Mevalonate Kinase Deficiency.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in TNF Receptor-Associated Periodic Syndrome
Dr. Hui Wang
Hematology | Oncology
Advanced in TNF Receptor-Associated Periodic Syndrome
Dr. Hui Wang
Hematology | Oncology

Providence Regional Cancer System - Centralia

2015 Cooks Hill Road, Suite 200, 
Centralia, WA 
360-330-8939
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Wang is board certified in medical oncology and internal medicine. She completed a medical oncology fellowship at the Fred Hutchinson Cancer Research Center and the University of Washington in Seattle. She completed her residency training at the Medical University of Ohio, where she also received a Ph.D. in biochemistry and molcular biology. D.r Wang earned her medical degree from Shandong Medical University in China. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of TNF Receptor-Associated Periodic Syndrome. She is also highly rated in 32 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), Large-Cell Immunoblastic Lymphoma, Vertebroplasty, and Bone Graft. Dr. Wang is board certified in American Board Of Internal Medicine. Dr. Wang is currently accepting new patients.

View All Doctors
What are the latest TNF Receptor-Associated Periodic Syndrome Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center